| 
						U.S. watchdog expands 
						scrutiny to more Chinese deals 
		 Send a link to a friend 
		
		 [October 11, 2016] 
		By Greg Roumeliotis 
 (Reuters) - 
		Insurance 
		mergers and acquisitions rarely raise red flags with U.S. national 
		security watchdogs. China's Fosun International Ltd <0656.HK> took that 
		history to heart last year when it paid $1.84 billion for the remaining 
		80 percent stake of U.S. property and casualty insurer Ironshore Inc 
		that it did not already own.
 
 But in December 2015, one month after Fosun completed the acquisition, 
		it was approached by officials at the Committee on Foreign Investment in 
		the United States (CFIUS), a government panel that scrutinizes deals 
		over national security concerns, according to people familiar with the 
		matter who asked not to be identified because these details are not 
		public.
 
 CFIUS was concerned about how Fosun would operate Ironshore's Wright & 
		Co, a provider of professional liability coverage to U.S. government 
		employees such as law enforcement personnel and national security 
		officials, including the Central Intelligence Agency, according to these 
		sources.
 
 Fosun, Ironshore and CFIUS all declined to comment on the process.
 
 CFIUS operates a voluntary filing system for companies engaged in a 
		deal. Such an instance of the panel approaching companies after they 
		complete a deal is rare.
 
 But the recent U.S. scrutiny of Fosun -- which did not seek CFIUS 
		approval for the Ironshore deal -- is just one example of a new impetus 
		by CFIUS to target what it refers to as "non-notified transactions" -- 
		or deals that did not seek CFIUS approval in advance.
 
		
		 
		In the last twelve months CFIUS has stepped up its pursuit of these 
		non-filers over concerns that some deals were falling through the 
		cracks, according to sources with direct knowledge of the panel's inner 
		workings. This previously unreported push by CFIUS has the potential to 
		delay some deals and raises the risk of them being thwarted altogether.
 While Wright accounted for a tiny fraction of Ironshore's business, the 
		inquiry has forced Fosun to delay its initial public offering of 
		Ironshore, which has been registered with the U.S. Securities and 
		Exchange Commission since June, until CFIUS clears the original 
		acquisition. Fosun will now likely miss a window for IPOs due to the 
		expected market volatility around the Nov. 8 U.S. presidential election, 
		according to the sources.
 
 Chinese companies have been treated with suspicion by CFIUS because of 
		the ties many of them have to the country's communist regime, reflecting 
		the complicated diplomatic and commercial ties between China and the 
		United States.
 
 This has not stopped Premier Li Keqiang's "going out" policy, which 
		encourages Chinese companies to buy foreign trophy assets. The push -- 
		aided by CFIUS's history of rarely shooting down deals altogether -- 
		contributed to Chinese M&A activity in the United States reaching a 
		record high of $32 billion so far this year.
 
 To be sure, CFIUS has approached companies in the past as well, and does 
		not limit its review to only Chinese deals. In 2010, CFIUS contacted 
		Russian internet company CMail.ru and AOL Inc over the latter's $188 
		million divestment of messaging service ICQ to Cmail.ru, which had 
		already been completed. The CFIUS review in that instance did not 
		require the deal to be unraveled.
 
 On rare occasions, the panel has also vetoed deals, such as the $3.3 
		billion sale of Koninklijke Philips NV's  lighting business to a 
		consortium of Chinese investors, which it blocked last January.
 
 But Ironshore and similar cases this year show that the U.S. watchdog is 
		flexing its muscles in a more subtle, albeit disruptive, fashion.
 
 "Companies may assume that there is no chance that CFIUS would have an 
		interest in their transaction, but that runs the risk of possible 
		miscalculation," said Eric Dinallo, a partner at law firm Debevoise & 
		Plimpton LLP.
 
 RISING SCRUTINY
 
 CFIUS, an agency made up of eight U.S. government departments and 
		chaired by the Treasury Secretary, does not publicize the reasons for 
		its decisions. The majority of transactions involve private companies 
		with no SEC filings.
 
		
		 
		Recent regulatory filings and statements by publicly listed companies, 
		however, offer glimpses of CFIUS catching some companies off guard. U.S. 
		electronics distributor Ingram Micro Inc <IM.N> said in July it would 
		seek CFIUS approval for its acquisition by Chinese shipping company 
		Tianjin Tianhai Investment, despite saying in February it did not need 
		to, following "consultation" with CFIUS.
 As a result, in August Ingram Micro pushed back the deadline for the 
		deal with Tianjin to close by three months to Nov. 13. CFIUS is 
		interested in learning more about the company's supply of technology to 
		the U.S. government, according to the sources. Ingram Micro and Tianjin 
		Tianhai declined to comment.
 
 CFIUS has added staff and resources in the last two years to identify 
		non-notified transactions, the sources said, though the number of 
		additional people recruited or the extra funding it was given could not 
		be learned.
 
 Among the CFIUS staffers playing a role in identifying non-filers, 
		alongside CFIUS Staff Chairman Stephen Hanson and Treasury Deputy 
		Assistant Secretary for Investment Security Aimen Mir, is Brian Reissaus, 
		a former member of the Defense Security Service, an agency of the U.S. 
		Department of Defense, according to the sources. Reissaus will often be 
		the CFIUS staffer reaching out to companies, the sources said.
 
			
            [to top of second column] | 
            
			
			 
            
			A Chinese national flag (L) flies in front of a building of the 
			headquarters of Fosun International, in Shanghai, China, March 29, 
			2016. REUTERS/Aly Song 
            
			
 
A 
Treasury spokesman declined to comment on behalf of CFIUS and the staffers. 
Chinese government officials declined to comment on CFIUS's new focus. 
CAUGHT OFF-GUARD
 CFIUS's crackdown on these non-notified transactions shows how the agency's 
focus has expanded beyond traditional sectors of national security concern, such 
as aerospace and semiconductors, to less obvious areas ranging from commercial 
IT and agriculture to biomedical science and electronics.
 
 Companies whose deals are reviewed by CFIUS without having made voluntary 
filings risk delays in completing them and uncertainty over their investment 
plans, lawyers say.
 
 In the case of Fosun, to ensure CFIUS approval Ironshore agreed to sell Wright 
last month to former American International Group Inc <AIG.N> CEO Hank 
Greenberg's Starr Companies, according to the sources.
 
 
In 
light of this divestment and other conversations it had with CFIUS, the company 
has reset the CFIUS review process by making another filing with the panel, and 
an outcome is expected in the coming weeks, one of the sources added.
 In the interim, Fosun has been exploring selling Ironshore outright as an 
alternative to an IPO, according to the sources.
 
 HELL OR HIGH WATER
 
 Some companies resist filing for a CFIUS review voluntarily because they fear 
that addressing this issue during their tough merger negotiations will add an 
extra layer of complexity to the talks, and some times risk complicating them to 
the point that a deal is not reached.
 
 This is because, once the possibility of a CFIUS review is foreseen in a merger 
contract, companies have to haggle over who assumes the financial risk under 
various scenarios.
 
Sellers try to push for "hell-or-high-water" provisions in contracts requiring 
the buyers to do whatever it takes in terms of divestitures and other measures 
to obtain CFIUS approval. Buyers resist this and seek to negotiate in advance 
what CFIUS remedies would be acceptable to them.
 A case in point is Zhongwang USA LLC, which is backed by Chinese aluminum 
magnate Liu Zhongtian, and its $2.33 billion deal last month to acquire U.S. 
aluminum company Aleris Corp <ALSD.PK>. Zhongwang USA agreed to "undertake best 
efforts to obtain CFIUS clearance as soon as practicable," while also limiting 
any CFIUS-related divestitures it would be willing to accept to 5 percent of 
Aleris' 2015 U.S. net sales, a regulatory filing shows.
 
 
The heightened scrutiny is also jacking up CFIUS-related breakup fees that 
buyers have to agree to in order to get a deal done, with sellers often asking 
these to be deposited in escrow accounts for more security. In the case of 
Zhongwang, it placed its $100 million breakup fee in an escrow account when it 
signed its deal with Aleris. 
Taken 
together, CFIUS lawyers and other consultants are advising their clients to 
proactively file with the agency to get out in front of the scrutiny.
 "Go to CFIUS before you close a transaction," said Dinallo. "Our experience has 
been that, if there is no issue, CFIUS has been quick to respond."
 
 For a graphic of CFIUS cases over the years click http://fingfx.thomsonreuters.com/gfx/rngs/CFUIS-CHINA/010021WF4MY/CFIUS-CHINA.jpg
 
 For a graphic of how China has accelerated purchases of U.S. companies click 
http://fingfx.thomsonreuters.com/gfx/rngs/CFIUS-CHINA/010021ZG4XT/CFIUS-CHINA-DEALS.jpg
 
 (Additional reporting by Diane Bartz in Washington D.C., Mike Stone in New York 
and Sue-Lin Wong in Beijing; Editing by Carmel Crimmins and Edward Tobin)
 
				 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			 |